Table 1.

Patient's peripheral blood lymphocyte subpopulations 4 months after liver-small bowel transplantation*



Total lymphocytes, %

TCRαβ, %

TCRγδ, %
Marker
Patient
Control
Patient
Control
Patient
Control
CD3+  90.5 ± 2.4   73.0 ± 2.5   23.0 ± 4.7   93.0 ± 2.1   77.0 ± 4.7   6.5 ± 0.7  
CD3+ CD4 CD8  61.2 ± 6.2   3.1 ± 0.6   3.1 ± 2.7   0.3 ± 0.0   85.7 ± 5.1   1.1 ± 0.3  
CD3+ CD4+ CD8  1.8 ± 0.8   43.0 ± 2.6   97.1 ± 1.0   99.0 ± 1.6   6.3 ± 3.1   0.1 ± 0.0  
CD3+ CD4 CD8+  28.3 ± 2.5   27.0 ± 1.6   33.3 ± 2.1   93.0 ± 2.3   60.0 ± 5.6   6.3 ± 1.3  
CD3+ CD4 CD8αβ  10.6 ± 1.8   —   2.7 ± 0.6   —   87.5 ± 5   —  
CD3+ CD4 CD8αα  19.6 ± 1.1   —   87.7 ± 1.4   —   14.6 ± 4.1   —  
CD19+  2.2 ± 0.8   12.5 ± 1.4   —   —   —   —  
CD56+
 
1.9 ± 1.2
 
13.3 ± 1.6
 

 

 

 

 


Total lymphocytes, %

TCRαβ, %

TCRγδ, %
Marker
Patient
Control
Patient
Control
Patient
Control
CD3+  90.5 ± 2.4   73.0 ± 2.5   23.0 ± 4.7   93.0 ± 2.1   77.0 ± 4.7   6.5 ± 0.7  
CD3+ CD4 CD8  61.2 ± 6.2   3.1 ± 0.6   3.1 ± 2.7   0.3 ± 0.0   85.7 ± 5.1   1.1 ± 0.3  
CD3+ CD4+ CD8  1.8 ± 0.8   43.0 ± 2.6   97.1 ± 1.0   99.0 ± 1.6   6.3 ± 3.1   0.1 ± 0.0  
CD3+ CD4 CD8+  28.3 ± 2.5   27.0 ± 1.6   33.3 ± 2.1   93.0 ± 2.3   60.0 ± 5.6   6.3 ± 1.3  
CD3+ CD4 CD8αβ  10.6 ± 1.8   —   2.7 ± 0.6   —   87.5 ± 5   —  
CD3+ CD4 CD8αα  19.6 ± 1.1   —   87.7 ± 1.4   —   14.6 ± 4.1   —  
CD19+  2.2 ± 0.8   12.5 ± 1.4   —   —   —   —  
CD56+
 
1.9 ± 1.2
 
13.3 ± 1.6
 

 

 

 

 

Values presented as mean ± standard error of the mean (SEM). CD indicates cluster of differentiation; TCR, T-cell receptor; and —, not assessed.

*

Absolute lymphocyte number 1.65 × 109/L. Ninety-nine percent of CD3+ cells and 45% of CD19+ cells were of donor origin at the time of this analysis.

CD8αβ and CD8αα frequencies were not assessed on the control population.

Close Modal

or Create an Account

Close Modal
Close Modal